Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RuiRong Yuan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Hematology & Oncology|October 29, 2009
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapyRuirong Yuan, Andrea Kay, William J Berg, et al.
Journal of Hematology & Oncology|December 20, 2014
Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastomaDebra Ehrlich, Bo Wang, Wei Lu, et al.
Journal of Hematology & Oncology|November 25, 2010
Targeted therapy in lymphomaPatrick B Johnston, RuiRong Yuan, Franco Cavalli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 15, 2015
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue ProtectionRuiRong Yuan, Bo Wang, Wei Lu, et al.
Journal of Hematology & Oncology|April 18, 2015
Pass quantity, focus on qualityDelong Liu, Weijing Sun, Jingzhou Hou, et al.
Plos One|April 3, 2008
Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAERuiRong Yuan, Yasuhiro Maeda, Weiping Li, et al.
Journal of Hematology & Oncology|January 27, 2017
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical PerspectiveJun Wang, Ruirong Yuan, Wenru Song, et al.
Pediatric Blood & Cancer|November 13, 2010
Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusionZhipeng Li, Rong Yang, Jiangning Zhao, et al.
Journal of Hematology & Oncology|January 15, 2011
Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumorsBingHe Xu, YiLong Wu, Lin Shen, et al.
Science (New York, N.Y.)|May 25, 2023
US "China initiatives" promote racial biasShan-Lu Liu, Lishan Su, Kunxin Luo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|October 29, 2009
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapyRuirong Yuan, Andrea Kay, William J Berg, et al.
Journal of Hematology & Oncology|December 20, 2014
Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastomaDebra Ehrlich, Bo Wang, Wei Lu, et al.
Journal of Hematology & Oncology|November 25, 2010
Targeted therapy in lymphomaPatrick B Johnston, RuiRong Yuan, Franco Cavalli, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 15, 2015
A Distinct Region in Erythropoietin that Induces Immuno/Inflammatory Modulation and Tissue ProtectionRuiRong Yuan, Bo Wang, Wei Lu, et al.
Journal of Hematology & Oncology|April 18, 2015
Pass quantity, focus on qualityDelong Liu, Weijing Sun, Jingzhou Hou, et al.
Plos One|April 3, 2008
Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAERuiRong Yuan, Yasuhiro Maeda, Weiping Li, et al.
Journal of Hematology & Oncology|January 27, 2017
PD-1, PD-L1 (B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical PerspectiveJun Wang, Ruirong Yuan, Wenru Song, et al.
Pediatric Blood & Cancer|November 13, 2010
Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusionZhipeng Li, Rong Yang, Jiangning Zhao, et al.
Journal of Hematology & Oncology|January 15, 2011
Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumorsBingHe Xu, YiLong Wu, Lin Shen, et al.
Science (New York, N.Y.)|May 25, 2023
US "China initiatives" promote racial biasShan-Lu Liu, Lishan Su, Kunxin Luo, et al.
Pageof 1